Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 160

1.

Caveolin 1 mRNA is overexpressed in malignant renal tissue and might serve as a novel diagnostic marker for renal cancer.

Waalkes S, Eggers H, Blasig H, Atschekzei F, Kramer MW, Hennenlotter J, Tränkenschuh W, Stenzl A, Serth J, Schrader AJ, Kuczyk MA, Merseburger AS.

Biomark Med. 2011 Apr;5(2):219-25. doi: 10.2217/bmm.11.12.

PMID:
21473727
2.

Fibronectin 1 mRNA expression correlates with advanced disease in renal cancer.

Waalkes S, Atschekzei F, Kramer MW, Hennenlotter J, Vetter G, Becker JU, Stenzl A, Merseburger AS, Schrader AJ, Kuczyk MA, Serth J.

BMC Cancer. 2010 Sep 22;10:503. doi: 10.1186/1471-2407-10-503.

3.

Caveolin 1 protein expression in renal cell carcinoma predicts survival.

Steffens S, Schrader AJ, Blasig H, Vetter G, Eggers H, Tränkenschuh W, Kuczyk MA, Serth J.

BMC Urol. 2011 Dec 7;11:25. doi: 10.1186/1471-2490-11-25.

4.

Reduced gene expression of bikunin as a prognostic marker for renal cell carcinoma.

Bayraktar E, Igci M, Erturhan S, Igci YZ, Karakok M, Gogebakan B, Ulasli M, Cakmak EA, Arslan A.

Exp Oncol. 2014 Jun;36(2):107-11.

PMID:
24980765
5.
6.

Wnt antagonist family genes as biomarkers for diagnosis, staging, and prognosis of renal cell carcinoma using tumor and serum DNA.

Urakami S, Shiina H, Enokida H, Hirata H, Kawamoto K, Kawakami T, Kikuno N, Tanaka Y, Majid S, Nakagawa M, Igawa M, Dahiya R.

Clin Cancer Res. 2006 Dec 1;12(23):6989-97.

7.

The overexpression of caveolin-1 and caveolin-2 correlates with a poor prognosis and tumor progression in esophageal squamous cell carcinoma.

Ando T, Ishiguro H, Kimura M, Mitsui A, Mori Y, Sugito N, Tomoda K, Mori R, Harada K, Katada T, Ogawa R, Fujii Y, Kuwabara Y.

Oncol Rep. 2007 Sep;18(3):601-9.

PMID:
17671707
8.

Is Stat3 and/or p53 mRNA expression a prognostic marker for renal cell carcinoma?

Masuda A, Kamai T, Abe H, Arai K, Yoshida K.

Biomed Res. 2009 Jun;30(3):171-6.

9.

Microarray-based identification of CUB-domain containing protein 1 as a potential prognostic marker in conventional renal cell carcinoma.

Awakura Y, Nakamura E, Takahashi T, Kotani H, Mikami Y, Kadowaki T, Myoumoto A, Akiyama H, Ito N, Kamoto T, Manabe T, Nobumasa H, Tsujimoto G, Ogawa O.

J Cancer Res Clin Oncol. 2008 Dec;134(12):1363-9. doi: 10.1007/s00432-008-0412-4. Epub 2008 May 16.

PMID:
18483744
10.

Increased expression of system large amino acid transporter (LAT)-1 mRNA is associated with invasive potential and unfavorable prognosis of human clear cell renal cell carcinoma.

Betsunoh H, Fukuda T, Anzai N, Nishihara D, Mizuno T, Yuki H, Masuda A, Yamaguchi Y, Abe H, Yashi M, Fukabori Y, Yoshida K, Kamai T.

BMC Cancer. 2013 Oct 30;13:509. doi: 10.1186/1471-2407-13-509.

11.

Hypoxia-inducible factor-2alpha mRNA expression in human renal cell carcinoma.

Sandlund J, Ljungberg B, Wikström P, Grankvist K, Lindh G, Rasmuson T.

Acta Oncol. 2009;48(6):909-14. doi: 10.1080/02841860902824891.

PMID:
19322701
12.

Tyrosine kinase expression profile in clear cell renal cell carcinoma.

Behbahani TE, Thierse C, Baumann C, Holl D, Bastian PJ, von Ruecker A, Müller SC, Ellinger J, Hauser S.

World J Urol. 2012 Aug;30(4):559-65. doi: 10.1007/s00345-011-0767-z. Epub 2011 Oct 4.

PMID:
21969129
13.

Overexpression of XIAP expression in renal cell carcinoma predicts a worse prognosis.

Mizutani Y, Nakanishi H, Li YN, Matsubara H, Yamamoto K, Sato N, Shiraishi T, Nakamura T, Mikami K, Okihara K, Takaha N, Ukimura O, Kawauchi A, Nonomura N, Bonavida B, Miki T.

Int J Oncol. 2007 Apr;30(4):919-25.

PMID:
17332931
14.

Protein expression of ZEB2 in renal cell carcinoma and its prognostic significance in patient survival.

Fang Y, Wei J, Cao J, Zhao H, Liao B, Qiu S, Wang D, Luo J, Chen W.

PLoS One. 2013 May 2;8(5):e62558. doi: 10.1371/journal.pone.0062558. Print 2013.

15.

The L1 cell adhesion molecule is induced in renal cancer cells and correlates with metastasis in clear cell carcinomas.

Allory Y, Matsuoka Y, Bazille C, Christensen EI, Ronco P, Debiec H.

Clin Cancer Res. 2005 Feb 1;11(3):1190-7.

16.
17.
18.

GATA5 CpG island methylation in renal cell cancer: a potential biomarker for metastasis and disease progression.

Peters I, Eggers H, Atschekzei F, Hennenlotter J, Waalkes S, Tränkenschuh W, Grosshennig A, Merseburger AS, Stenzl A, Kuczyk MA, Serth J.

BJU Int. 2012 Jul;110(2 Pt 2):E144-52. doi: 10.1111/j.1464-410X.2011.10862.x. Epub 2012 Jan 30.

19.

Decreased selenium-binding protein 1 mRNA expression is associated with poor prognosis in renal cell carcinoma.

Ha YS, Lee GT, Kim YH, Kwon SY, Choi SH, Kim TH, Kwon TG, Yun SJ, Kim IY, Kim WJ.

World J Surg Oncol. 2014 Sep 16;12:288. doi: 10.1186/1477-7819-12-288.

20.

Down-regulation of PKCζ in renal cell carcinoma and its clinicopathological implications.

Pu YS, Huang CY, Chen JY, Kang WY, Lin YC, Shiu YS, Chuang SJ, Yu HJ, Lai MK, Tsai YC, Wu WJ, Hour TC.

J Biomed Sci. 2012 Apr 5;19:39. doi: 10.1186/1423-0127-19-39.

Supplemental Content

Support Center